Concepedia

Francesco Caprioni

FC

6

Publications

316

Citations

6

H-Index

2007

Active since

Affiliations

Ospedale Policlinico San Martino(Current)

Azienda Ospedaliero-Universitaria di Modena

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Vita-Salute San Raffaele University

MolMed (Italy)

Francesco Caprioni is an author at Ospedale Policlinico San Martino specializing in oncology, radiation oncology, and medicine.

Top concepts

MedicineOncologyRadiation OncologyPathologyPharmacologyCancer TherapyCancer ResearchColorectal CancerPharmacotherapyMolecular Oncology

Publications per year

2007–2018

6

Publications

6

A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.

Bertram Wiedenmann, Peter Malfertheiner, Helmut Friess et al. · PubMed · 2008 · 144 citations

Pancreatic Cancer, Phase Ii, Cancer Cachexia +13

Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

Stefano Cascinu, Rossana Berardi, Alberto F. Sobrero et al. · Digestive and Liver Disease · 2013 · 50 citations

Oncology, Pancreatic Cancer, Gastrointestinal Oncology +9

First-line single-agent cetuximab in patients with advanced colorectal cancer

A. Pessino, Salvatore Artale, Stefania Sciallero et al. · Annals of Oncology · 2007 · 46 citations

Gastrointestinal Oncology, Medicine, Colorectal Cancer +4

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

Armando Santoro, Lorenza Rimassa, Alberto Sobrero et al. · European Journal of Cancer · 2010 · 42 citations

Selective Vascular, Medicine, Pharmacology +7

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Serafina Mammoliti, V. Andretta, E. Bennicelli et al. · Annals of Oncology · 2010 · 18 citations · Full text

Rows per page

1–5 of 6